Y-Intercept (HK)’s Accendra Health ACH Stock Holding History

Y-Intercept (HK)’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37,443	Closed	-$105K	–	1919
2025 Q4	$105K	Sell	37,443 -545,304	-94%	-$1.95M	﹤0.01%	1468
2025 Q3	$2.8M	Buy	582,747 +324,100	+125%	+$2.06M	0.07%	435
2025 Q2	$2.35M	Buy	+258,647	New	+$1.91M	0.06%	526
2024 Q3	–	Sell	-96,360	Closed	-$1.3M	–	1661
2024 Q2	$1.3M	Buy	96,360 +73,075	+314%	+$1.5M	0.07%	386
2024 Q1	$645K	Sell	23,285 -7,145	-23%	-$159K	0.05%	585
2023 Q4	$586K	Buy	+30,430	New	+$551K	0.05%	526
2023 Q3	–	Sell	-10,816	Closed	-$206K	–	1438
2023 Q2	$206K	Sell	10,816 -7,111	-40%	-$127K	0.02%	929
2023 Q1	$261K	Buy	+17,927	New	+$321K	0.03%	838

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Y-Intercept (HK)'s ACH Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Accendra Health (ACH) in Q1 2026, closing a stake of 37,443 shares — an estimated $105K sold.

Y-Intercept (HK) first reported a position in ACH in Q1 2023 and held it in 8 quarters. The position peaked at $2.8M in Q3 2025. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

Y-Intercept (HK) reported no remaining Accendra Health position as of Q1 2026 after selling out during the quarter.
Y-Intercept (HK) sold 37,443 Accendra Health shares in Q1 2026, an estimated $105K.
Y-Intercept (HK) first reported a position in Accendra Health in Q1 2023 and held it in 8 quarters.
Y-Intercept (HK)'s Accendra Health position peaked at $2.8M in Q3 2025.
142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.